Table 2 Baseline characteristics and biochemical data of the study participants with and without major adverse cardiovascular events
From: The burden of major adverse cardiac events in patients with coronary artery disease
Variable | Total | With MACE | Without MACE | P-value |
|---|---|---|---|---|
No | 1520 | 558 | 962 | Â |
Age (years) | 68.9 ± 12.0 | 71.9 ± 11.7 | 67.2 ± 11.9 | <0.0001 |
Body mass index (kg/m2) | 25.7 ± 10.6 | 25.2 ± 4.4 | 26.0 ± 12.9 | 0.186 |
Waist circumference (cm) | 91.0 ± 10.4 | 91.9 ± 10.5 | 90.4 ± 10.2 | 0.021 |
Waist to hip ratio | 0.94 ± 0.11 | 0.95 ± 0.14 | 0.93 ± 0.08 | <0.0001 |
Systolic BP (mmHg) | 133 ± 22 | 133 ± 24 | 132 ± 21 | 0.298 |
Diastolic BP (mmHg) | 77 ± 14 | 75 ± 14 | 77 ± 13 | 0.008 |
HbA1C (%) | 7.0 ± 1.8 | 7.1 ± 1.9 | 6.9 ± 1.7 | 0.012 |
Fasting glucose (mg/dl) | 144.9 ± 77.0 | 159.5 ± 88.7 | 136.4 ± 68.0 | <0.0001 |
Total cholesterol (mg/dl) | 177.1 ± 45.5 | 174.9 ± 45.3 | 178.4 ± 45.5 | 0.156 |
Triglycerides (mg/dl) | 143.8 ± 105.2 | 138.1 ± 93.3 | 147.0 ± 111.2 | 0.116 |
HDL-cholesterol (mg/dl) | 40.2 ± 12.0 | 38.6 ± 11.9 | 41.0 ± 12.0 | 0.0002 |
LDL-cholesterol (mg/dl) | 103.7 ± 35.4 | 104.4 ± 37.1 | 103.2 ± 34.3 | 0.518 |
Creatinine (mg/dl) | 1.74 ± 1.83 | 2.0 ± 2.3 | 1.6 ± 1.5 | <0.0001 |
Uric acid (mg/dl) | 6.8 ± 2.7 | 7.0 ± 2.1 | 6.6 ± 3.0 | 0.017 |
eGFR (ml/min/1.73 m2) | 57.2 ± 23.1 | 51.4 ± 23.0 | 60.5 ± 22.6 | <0.0001 |
Hs-CRP (mg/L) | 12.2 ± 32.4 | 14.0 ± 36.8 | 11.0 ± 29.1 | 0.001 |
White blood cell (109/l) | 8.469 ± 3.877 | 8.795 ± 3.699 | 8.279 ± 3.967 | 0.012 |
Red blood cell (10 6/μl) | 4.54 ± 1.21 | 4.46 ± 0.94 | 4.58 ± 1.34 | 0.030 |
Hemoglobin (g/dl) | 13.2 ± 2.3 | 13.1 ± 2.6 | 13.3 ± 2.1 | 0.033 |
Hematocrit (%) | 39.5 ± 6.1 | 39.1 ± 6.3 | 39.8 ± 5.9 | 0.039 |
Mean corpuscular volume (fL) | 88.4 ± 7.7 | 88.6 ± 7.9 | 88.2 ± 7.6 | 0.320 |
MCH (pg/cell) | 29.8 ± 7.4 | 29.6 ± 3.0 | 30.0 ± 9.1 | 0.323 |
MCHC (g/dL) | 33.4 ± 1.3 | 33.3 ± 1.4 | 33.5 ± 1.2 | <0.0001 |
Malnutrition indicator score | 24.7 ± 3.5 | 23.9 ± 3.6 | 25.1 ± 3.3 | 0.010 |